SpringWorks Therapeutics to Participate in the BofA Securities 2024 Health Care Conference
May 08, 2024 07:00 ET
|
SpringWorks Therapeutics, Inc.
STAMFORD, Conn., May 08, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today...
Sprott Announces First Quarter 2024 Results
May 08, 2024 07:00 ET
|
Sprott Inc.
TORONTO, May 08, 2024 (GLOBE NEWSWIRE) -- Sprott Inc. (NYSE/TSX: SII) (“Sprott” or the “Company”) today announced its financial results for the quarter ended March 31, 2024. Management commentary...
Brink's Announces Strong First-Quarter Results and Affirms Full Year Guidance
May 08, 2024 07:00 ET
|
The Brink’s Company
Record First Quarter Revenue Reflecting 4% Growth and 12% Organic GrowthGAAP net income up 229% to $49M and record adjusted EBITDA up 15% to $218MGAAP EPS up 263% to $1.09 and non-GAAP EPS up 20% to...
Chemomab Therapeutics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
May 08, 2024 07:00 ET
|
Chemomab Therapeutics
Chemomab has been granted another 180-day extension to regain compliance with the minimum bid price requirement in order to remain listed on Nasdaq.
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Innoviz
May 08, 2024 07:00 ET
|
Faruqi & Faruqi LLP
NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Innoviz Technologies Ltd. (“Innoviz” or the...
Achilles Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
May 08, 2024 07:00 ET
|
Achilles Therapeutics PLC
– Provided interim Phase I/IIa update on clonal neoantigen reactive T cells in advanced NSCLC and melanoma – – Evaluating the benefit of enhanced host conditioning with further data expected in 2H...
Aura Biosciences to Participate in Upcoming Investor Conferences
May 08, 2024 07:00 ET
|
Aura Biosciences, Inc.
BOSTON, May 08, 2024 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision immunotherapies to treat solid tumors designed to preserve...
Bio-Path Holdings to Announce First Quarter 2024 Financial Results on May 15, 2024
May 08, 2024 07:00 ET
|
Bio-Path Holdings, Inc.
HOUSTON, May 08, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a...
1stDibs Reports First Quarter 2024 Financial Results
May 08, 2024 07:00 ET
|
1stDibs.com, Inc.
NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- 1stdibs.com, Inc. (NASDAQ: DIBS), a leading online marketplace for luxury design products ("1stDibs" or the "Company"), today reported financial results...
Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic Controllers
May 08, 2024 07:00 ET
|
Omega Therapeutics
Programmable epigenomic mRNA candidates enabled durable and robust upregulation of gene expression across a diverse set of gene types and regulatory mechanismsAdditional OMEGA platform capabilities...
- May 08, 2024 06:01 ET Asia-Pacific Wind-Assisted Propulsion Industry Research 2024: China, Japan, and South Korea are Emerging as Key Players - Forecasts to 2032
- May 08, 2024 06:00 ET Global Colonoscopy Devices Market Outlook 2024-2030: Awareness Campaigns, End-user Adoption Rates, Technological Advancements, Leading Players